Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Clinical trial nct04512345 roflumilast intervention?

What is NCT04512345 and what intervention is being tested?

NCT04512345 is a clinical trial registered on ClinicalTrials.gov. The “intervention” in the record is roflumilast. That means the study is testing roflumilast in a defined patient population under a specific protocol (dose, schedule, duration, and comparator depend on the study arm described in the listing).

What condition is NCT04512345 studying roflumilast for?

ClinicalTrials.gov trial records like NCT04512345 typically specify the disease/indication (for example, COPD-related indications) and whether roflumilast is used alone or with other therapies. To answer this precisely, the key fields are the trial’s “Condition” and “Intervention” sections on the NCT04512345 page.

What phase is the trial, and is it randomized?

The NCT04512345 record also indicates the trial phase (e.g., Phase 1/2/3), whether it is randomized, and whether it uses a placebo or an active comparator. Those details determine how to interpret results and how patients might compare it with standard care.

How can I find the exact dosing and study design for roflumilast in this trial?

On the NCT04512345 page, look for:
- “Arms and Interventions” (roflumilast dose and schedule, control arm)
- “Study Design” (randomization, masking, number of arms)
- “Primary Outcome Measures” (what effect the trial is designed to show)

If you paste the “Interventions” text from the NCT04512345 listing here, I can translate it into plain English (dose, duration, comparator, and what endpoints are being measured).

Is roflumilast the only intervention, or is it combined with other drugs?

Some trials test roflumilast alongside standard background therapy (such as inhaled medications) rather than as a stand-alone drug. The “Arms and Interventions” section will clarify whether roflumilast is monotherapy or add-on therapy.

Trial status and results: has NCT04512345 been completed?

ClinicalTrials.gov shows whether the trial is recruiting, active, completed, or terminated, plus any posted results. The status affects whether there are findings to interpret yet.

Where to check the official trial record

Use the official ClinicalTrials.gov listing for NCT04512345 for the authoritative intervention wording, dosing, eligibility criteria, and outcomes.

If you want, tell me your goal—(1) summarize the trial, (2) extract dosing/comparator, (3) check outcomes/results, or (4) assess eligibility for enrollment—and I’ll tailor the answer to that.



Other Questions About Clinical :

How do clinical trials prove polivy's effectiveness? What clinical trials show sapropterin's effectiveness? What results from clinical trials support polivy's use? Which clinical trials show polivy's efficacy? What results from clinical trials support polivy's use? Which clinical trials show polivy's efficacy? How do clinical trials prove polivy's effectiveness?